triazoles has been researched along with Lupus Nephritis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finkelman, FD; Lee, IJ; Shao, WH; Zhen, Y | 1 |
| Sha, H; Sun, Y; Wei, S | 1 |
| Albom, MS; Angeles, TS; Ator, MA; Dobrzanski, P; Dorsey, BD; Dugan, BJ; Gingrich, DE; Lu, LD; Mason, JL; Ruggeri, BA; Seavey, MM; Serdikoff, C; Stump, KL; Wallace, NH | 1 |
| Beom, SH; Chin, HJ; Kim, S; Kim, YC; Lee, H; Ryu, HH; Yang, Y | 1 |
| Putterman, C; Tagoe, C | 1 |
| Aomori, T; Araki, T; Fujita, Y; Hiromura, K; Nakamura, T; Nojima, Y; Okada, Y; Shimizu, R; Tomizawa, T; Yamamoto, K | 1 |
6 other study(ies) available for triazoles and Lupus Nephritis
| Article | Year |
|---|---|
Targeted inhibition of Axl receptor tyrosine kinase ameliorates anti-GBM-induced lupus-like nephritis.
Topics: Administration, Oral; Animals; Antibodies; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Cell Line, Transformed; Drug Administration Schedule; Gene Expression Regulation; Glomerular Basement Membrane; Immunologic Factors; Intercellular Signaling Peptides and Proteins; Lupus Nephritis; Mesangial Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Targeted Therapy; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor Protein-Tyrosine Kinases; RNA, Small Interfering; Signal Transduction; Sp1 Transcription Factor; Sp3 Transcription Factor; Triazoles | 2018 |
Therapeutic targeting of BET protein BRD4 delays murine lupus.
Topics: Animals; Azepines; Disease Progression; DNA; Humans; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred MRL lpr; Monocytes; Nerve Tissue Proteins; Nuclear Proteins; Proteinuria; Receptors, Cell Surface; Spleen; Tetrazolium Salts; Thiazoles; Transcription Factors; Triazoles | 2015 |
Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2.
Topics: Administration, Oral; Animals; Antibodies, Antinuclear; Autoimmunity; Cell Separation; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Janus Kinase 2; Lupus Nephritis; Mice; Mice, Inbred MRL lpr; Plasma Cells; Pyridines; Triazoles | 2011 |
Aspergillus-associated cerebral aneurysm successfully treated by endovascular and surgical intervention with voriconazole in lupus nephritis patient.
Topics: Antifungal Agents; Female; Humans; Immunosuppressive Agents; Intracranial Aneurysm; Lupus Nephritis; Middle Aged; Neuroaspergillosis; Pyrimidines; Stents; Surgical Instruments; Triazoles; Voriconazole | 2012 |
JAK2 inhibition in murine systemic lupus erythematosus.
Topics: Animals; Disease Models, Animal; Humans; Interleukin-6; Janus Kinase 2; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Plasma Cells; Pyridines; Signal Transduction; Treatment Outcome; Triazoles | 2012 |
Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents.
Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Interactions; Female; Genotype; Humans; Immunosuppressive Agents; Itraconazole; Lupus Nephritis; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2013 |